HQL: Total Real Return Chart (Dividends Reinvested, Inflation Adjusted)

Fri 1992-05-01? to Tue 2026-01-13	YTD Return	TRR Price
HQL ×	−0.60% 2026-01-13	7.944 TRR 2026-01-13
Tekla Life Sciences Investors NYSE Common Stock

---

Returns

Fri 1992-05-01? to Tue 2026-01-13	Overall Return	Exponential Trendline
HQL ×	+694.38% +6.34%/yr	+7.58%/yr (R2=0.876)
Tekla Life Sciences Investors NYSE Common Stock

---

Growth of $10,000

Fri 1992-05-01? to Tue 2026-01-13	Start Value	End Value
HQL ×	$10,000.00 1992-05-01	$79,438.36 2026-01-13
Tekla Life Sciences Investors NYSE Common Stock

---

Annual Returns

Year	HQL
2026 (YTD)	−0.60%
2025	+41.69%
2024	+7.92%
2023	+0.83%
2022	−24.11%
2021	−1.44%
2020	+22.05%
2019	+22.76%
2018	−17.71%
2017	+22.87%
2016	−21.08%
2015	+5.00%
2014	+30.29%
2013	+49.81%
2012	+34.98%
2011	+13.01%
2010	+18.56%
2009	+11.81%
2008	−28.00%
2007	+3.05%
2006	−9.03%
2005	+8.12%
2004	+7.44%
2003	+39.59%
2002	−37.47%
2001	+12.70%
2000	+23.22%
1999	+76.58%
1998	−7.79%
1997	−1.04%
1996	+0.52%
1995	+62.47%
1994	−28.44%
1993	−18.47%
1992	−4.14%

---

Drawdowns

Fri 1992-05-01? to Tue 2026-01-13	Current Drawdown	Worst Drawdown
HQL ×	−5.60%	−64.71% 2009-03-09
Tekla Life Sciences Investors NYSE Common Stock